timolol has been researched along with Cranial Nerve II Injuries in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Born, CP | 1 |
| Schwartz, M; Wheeler, LA; Yoles, E | 1 |
2 other study(ies) available for timolol and Cranial Nerve II Injuries
| Article | Year |
|---|---|
Ocular injuries--treat or refer?
Topics: Acetazolamide; Adult; Burns, Chemical; Eye Injuries; Eyelids; Humans; Hyphema; Intraocular Pressure; Mannitol; Middle Aged; Optic Nerve Injuries; Physicians, Family; Referral and Consultation; Timolol; Visual Acuity; Wounds, Penetrating | 1983 |
Alpha2-adrenoreceptor agonists are neuroprotective in a rat model of optic nerve degeneration.
Topics: Action Potentials; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Axons; Brimonidine Tartrate; Cell Count; Cell Survival; Clonidine; Disease Models, Animal; Dose-Response Relationship, Drug; Injections, Intraperitoneal; Male; Nerve Degeneration; Neuroprotective Agents; Optic Nerve; Optic Nerve Diseases; Optic Nerve Injuries; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Retinal Ganglion Cells; Timolol; Yohimbine | 1999 |